New Elite Feature: Compare relative returns, fundamentals, and sector rankings head-to-head.

Kiniksa Pharmaceuticals International, Plc

Contributing Author

Recent Articles by Kiniksa Pharmaceuticals International, Plc

May-29	Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences KNSA GlobeNewswire
Apr-28	Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution KNSA +23.48% GlobeNewswire
Apr-23	Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026 KNSA GlobeNewswire
Apr-08	Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST (rilonacept) in Recurrent Pericarditis KNSA GlobeNewswire
Feb-25	Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference KNSA GlobeNewswire
Feb-24	Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution KNSA -8.21% GlobeNewswire
Feb-19	Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 KNSA GlobeNewswire
Jan-12	Kiniksa Pharmaceuticals Provides Corporate Update KNSA GlobeNewswire
Jan-07	Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference KNSA GlobeNewswire
Nov-12	Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London KNSA GlobeNewswire
Oct-28	Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution KNSA GlobeNewswire
Oct-23	Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025 KNSA GlobeNewswire
Oct-17	Kiniksa Pharmaceuticals Announces U.S. Orphan Drug Designation for KPL-387 for the Treatment of Pericarditis KNSA GlobeNewswire
Aug-28	Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences KNSA GlobeNewswire
Jul-29	Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution KNSA +12.32% GlobeNewswire
Jul-24	Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025 KNSA GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)